Digital Building an AI-native CRO Artificial intelligence is transforming nearly every industry. In clinical research, the question isn't whether to use AI, but how to use it meaningfully.
Digital Sponsored From Automation to Decision Intelligence: The Next Operating... In this free white paper, IQVIA experts and thought leaders explore the real challenges and bottlenecks in pharmacovigilance today.
R&D Scientists and algorithms: Finding the right balance in mode... The future of drug development is not scientists versus algorithms. It is scientists and algorithms working together.
R&D Agentic AI and the human element: Building trustworthy autom... The future of clinical trials isn’t about replacing people. It’s about empowering them with smarter tools.
Digital Sponsored Expert Directed Applied Intelligence: Redefining AI in Life ... In a new white paper from Lumanity, explore why the most powerful AI will always be human-directed.
Digital Regulators open the AI floodgates in life sciences In 2026, biopharma will move from proving AI works to proving it can be trusted at scale.
News Iambic prices its IPO, seeking to raise up to $160m AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
